Founded by researchers from the Human Protein Atlas
The Human Protein Atlas was initiated in 2003 by Swedish researchers, headed by Professor Mathias Uhlén, and is funded by the Knut and Alice Wallenberg foundation. It is a unique world-leading effort to create a complete map of human protein expression and localization in normal tissues, cancers, and cell lines. The project launched a first version of the complete human tissue proteome in 2016 as the Tissue Atlas, the subcellular proteome in 2017 and continues to add additional layers of knowledge exploring the human proteome.
|
|
Inmunotek is a pharmaceutical company based in Alcalá de Henares – Madrid (Spain) that researches, develops, manufactures and markets products in the field of Allergy and Immunology for the diagnosis and treatment of allergic and other immune-based diseases in human and veterinary medicines.
Inmunotek was founded in 1992 by Dr. Jose Luis Subiza, board-certified immunologist, on the premises of a small clinical laboratory set in the 50′ by Dr. Eliseo Subiza (1921-1998), allergist and pioneer of palynology in Spain.
From the outset, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
|
Leinco Technologies is a biotechnology company founded in 1992 as a specialty manufacturer of early discovery research products including antibodies, recombinant proteins, ELISA kits, second step reagents and other life sciences products. Shortly thereafter, they also established themselves as a premier provider of custom R&D and manufacturing services focusing on monoclonal antibodies and recombinant proteins. Their innovative products and services are used to augment the early discovery process in life science research, diagnostics and ground breaking development of protein therapeutics.
|
|
|
